Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Coave Therapeutics S.A.
BioCentury | Jan 11, 2025
Finance
Pre-JPM venture bonanza
Fourteen companies announce series A rounds ahead of conference, six with over $100 million
BioCentury | Sep 22, 2023
Management Tracks
Shields leaving BenevolentAI as CEO
Plus: Berns named interim CMO at Faron, and updates from Coave, Maxion, Nanoscope and Patient Square
BioCentury | May 20, 2022
Discovery & Translation
Optimizing CNS tropism for AAVs at ASGCT
Directed evolution, genetic library screening and peptide modifications were the most common strategies presented
BioCentury | Nov 16, 2021
Management Tracks
End of an era at Biogen as R&D head Sandrock readies to retire
Plus: Levin-Allerhand joins Flagship, and updates from Alchemab, Agios, Actym, Gilgamesh and more
BioCentury | Sep 30, 2021
Product Development
Gaucher disease pipeline: Data Byte
Three clinical and 11 preclinical candidates move beyond traditional enzyme replacement, aim for wider range of patients
Items per page:
1 - 5 of 5